ISPE Singapore Conference & Exhibition 2026
CPHI Korea 2026
Cold Chain Unbroken 2026
Uruguay Best Practices in Pharma Supply Chain 2026
Unique channel considerations when launching a cell or gene therapy
PDA Advanced Parenteral Therapeutics & Quality Summit 2026
LogiPharma 2026
Pharma Smart Manufacturing 2026
PDA Aseptic Manufacturing Excellence Conference 2026
PDA Aseptic Manufacturing and Regulatory Science Symposium 2026
BIOPLUS-INTERPHEX KOREA 2026
PDA Aseptic Processing of Biopharmaceuticals Conference 2026
HealthX Intelligence 2026 Conference
Testo – SaaS-Based Environmental Monitoring Systems: Risk, Regulatory Compliance and Validation
11th BioPharma Supply Chain & Logistics Nexus Conference
The Pharmaceutical Automation and Digitalisation Congress (AUTOMA+) 2026
LogiPharma Digital Supply Chain Connect announces 2026
London Biotechnology Show 2026
Pharma Supply Chain & Security World 2027 Conference
Global Clinical Trials Connect 2027 Conference
Digi-Tech Pharma & AI 2027 Conference
| 2026 |
2027 |
|---|
| Aug |
Sep |
Oct |
Nov |
Dec |
Jan |
Feb |
Mar |
Apr |
May |
|---|
| W34 |
W35 |
W36 |
W37 |
W38 |
W39 |
W40 |
W41 |
W42 |
W43 |
W44 |
W45 |
W46 |
W47 |
W48 |
W49 |
W50 |
W51 |
W52 |
W53 |
W01 |
W02 |
W03 |
W04 |
W05 |
W06 |
W07 |
W08 |
W09 |
W10 |
W11 |
W12 |
W13 |
W14 |
W15 |
W16 |
W17 |
W18 |
W19 |
|---|
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |
| | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | |